Saturday November 21 2009 | Biotechnology feed | All feeds
|
|
Genetronics Biomedical
Download detailed PDF Members: Genetronics' most advanced effort involves treating those with head and neck cancer, a particularly devastating cancer that can severely limit the ability of these patients to see, taste, hear, talk, breathe, or swallow. Genetronics received approval from the U.S. Food and Drug Administration and initiated Phase II multi-center clinical trials at nine sites in the U.S. The trials test the effectiveness of Genetronics’ proprietary drug delivery system as a treatment for cancer of the head and neck in patients with resistant or recurrent cancers who have failed conventional therapy. The Company also has approval from the Health Protection Branch in Canada and has also conducted multi-center clinical trials there.
This page has been viewed 1039 times since April 2007, the link to the organisation's website has been followed 207 times Recent Search Terms used to find this page: genetronics biomedical | genetronics | genetronics | Genetronics Biomedical | genetronics | GENETRONICS | GENETRONICS | genetronics | GENETRONICS BIOMED | GENETRONICS BIOMEDICAL | . Search for more companies in San Diego Search for more companies in CA This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for Genetronics Biomedical | ||||||||||||||||||||||||||||||||||
|